Supreme Cannabis (Fire) Withdraws Guidance – More Cost Cutting Needed
Supreme has growers who can actually grow good bud. As long as they sort out the cost structure,...
VFF
Aphria (APHA) Earnings – Guidance Cut But Still the Best Game in Town
Aphria has the cash to weather the coming storm and the profitability to match. The only safe haven in Canadian cannabis.
HEXO About to Learn What it Means to Sink or Swim After Scary Earnings Report
HEXO (NYSE: HEXO) Q1 2020 earnings were as scary as they come. Dwindling cash, falling prices, and rising...
Aphria Building a Gold Plated Balance Sheet With New $80 Million Financing
Improbably Aphria Inc. (TSX: APHA; NYSE: APHA) now looks like the most attractive large cap company in cannabis. We...
Canadian Cannabis Scorecard (Summer 2019)
Confused about which marijuana stocks are worth an investment? The Canadian Cannabis Scorecard is your guide to separating...
The Gimme 20% Return – Aphria Extraction Hack Explained
Aphria has an undervalued asset hiding in Leamington Ontario that could lead to an immediate 20% jump in the stock price.
Aurora Cannabis Q3 2019 Earnings Review – Holding Pattern Continues
Aurora (TSX: ACB) reported Q3 earnings and showed growth in revenue, gross profit while decreasing costs. However, concerns remain with their cash balance.
Aphria Q3 2019 Earnings Review – Headlines Create Opportunity
Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong revenue growth quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.